iDEL Therapeutics

Dortmund, Germany

iDEL Therapeutics is a cancer therapeutics company.

$10.4M raised

Mar 2026

Seed

Biotechnology Health Care Medical

Top Investors

BioMedPartnersGruenderfonds RuhrKHAN Technology Transfer FundNRW.Venture

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about iDEL Therapeutics

How much funding has iDEL Therapeutics raised?

iDEL Therapeutics has raised $10.4M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are iDEL Therapeutics's investors?

iDEL Therapeutics's investors include BioMedPartners, Gruenderfonds Ruhr, KHAN Technology Transfer Fund, NRW.Venture.

Where is iDEL Therapeutics headquartered?

iDEL Therapeutics is headquartered in Dortmund, Germany.

What does iDEL Therapeutics do?

iDEL Therapeutics is a cancer therapeutics company.

What stage is iDEL Therapeutics at?

iDEL Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 17, 2026.

MLA

"iDEL Therapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/idel-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2026). iDEL Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/idel-therapeutics

Wikipedia (cite web)

{{cite web |title=iDEL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/idel-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 17, 2026.

Similar Companies in Biotechnology